Christopher Cox
0000-0003-1547-0518
Publication & Citation Trends
Most Cited Works
Publications
390 total
Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia OA
Cited by 32
Semantic Scholar
Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor Interaction OA
Cited by 15
Semantic Scholar
Discovery, Optimization, and Biological Characterization of 2,3,6‐Trisubstituted Pyridine‐Containing M4 Positive Allosteric Modulators
Cited by 18
Semantic Scholar
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug design.
Cited by 13
Semantic Scholar
Current Landscape of Antiviral Drug Discovery OA
Cited by 32
Semantic Scholar
Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [11C]MK-8193
Cited by 11
Semantic Scholar
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.
Cited by 108
Semantic Scholar
Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia.
Cited by 21
Semantic Scholar
Research Topics
Air Quality and Health Impacts
(51)
Cardiac Imaging and Diagnostics
(48)
Mercury impact and mitigation studies
(47)
Heavy Metal Exposure and Toxicity
(37)
Advanced X-ray and CT Imaging
(27)
Frequent Co-Authors
Affiliations
Louisiana State University
Tufts University
University of Copenhagen
Brigham and Women's Hospital
Toshiba (Japan)